Adrian Howd
Non-Executive Director
Pharmaceutical
Altan
Spain
Biography
Dr. Adrian Howd currently serves as chief executive officer of Malin Plc. Prior to Malin, Dr. Howd held both sell-side and buy-side roles, being a highly ranked sell-side analyst at Berenberg, Nomura and ABN Amro where he was Global Head of Healthcare Research. He also gained buy-side experience running a healthcare portfolio as part of the Principal Strategies Group at ABN Amro. Dr. Howd also served as Executive Vice President, Head of Neuroscience and Corporate Development at Evotec AG. Dr. Howd has a Ph.D in molecular neuroscience from the University of London. Dr. Howd is a principal, director and shareholder of Brandon Point Industries and is also a director of Malin Plc.
Research Interest
Pharmaceuticals
